| SOXS 1.79 4.07% | NVDA 177.19 -4.16% | ONMD 1.02 44.60% | NFLX 96.24 13.77% | JEM 0.096 3.90% | ENSC 0.6232 57.77% | BYND 0.9456 15.32% | PLUG 1.79 -6.28% | SOFI 17.76 -7.02% | NVD 7.53 8.50% | TZA 6.23 5.06% | NU 14.98 -0.53% | DUST 3.54 -3.50% | BITO 9.06 -2.78% | EOSE 5.695 -15.50% | XLF 51.43 -2.04% | BAC 49.83 -4.72% | AAL 13.07 -6.24% | MARA 8.94 5.80% | VEEA 0.5071 17.33% | SPY 685.99 -0.48% | SOXL 62.77 -3.93% | SLV 84.99 5.64% | XWEL 1.49 9.56% | QQQ 607.29 -0.32% | ONDS 10.08 -3.54% | BHAT 0.0495 -11.13% | PSKY 13.51 20.84% | INTC 45.61 0.33% | F 14.095 -2.19% | AAPL 264.18 -3.21% | XLE 55.92 1.58% | TQQQ 49.52 -1.06% | TSLA 402.51 -1.49% | HYG 80.72 -0.16% | TSDD 9.18 2.91% | TSLL 14.7 -3.10% | BATL 5.52 33.01% | RKT 18.19 2.36% | RXT 1.95 -14.47% | TLT 90.82 0.61% | TSLS 5.64 1.62% | WBD 28.17 -2.19% | PATH 10.73 0.14% | CRWV 79.56 -18.51% | IBIT 37.19 -2.80% | LQD 111.68 -0.04% | SOUN 8.6015 -4.21% | PLTR 137.19 0.92% | CPNG 19.08 1.98%

AudioEye, Inc. (NASDAQ:AEYE) and Its Capital Efficiency Compared to Peers

AudioEye, Inc. (NASDAQ:AEYE) is a company that focuses on digital accessibility solutions, helping businesses make their digital content accessible to individuals with disabilities. The company operates in a competitive landscape with peers like Brightcove Inc., ClearPoint Neuro, Inc., Rekor Systems, Inc., DarioHealth Corp., and Apyx Medical Corporation. These companies, while operating in different sectors, share the common challenge of managing their capital efficiently.

AudioEye's Return on Invested Capital (ROIC) is -14.04%, which is significantly lower than its Weighted Average Cost of Capital (WACC) of 7.73%. This negative ROIC indicates that AudioEye is not generating enough returns to cover its cost of capital, which is a critical measure of financial health. The ROIC to WACC ratio of -1.82 further highlights this inefficiency in capital utilization.

When comparing AudioEye to its peers, Brightcove Inc. emerges as the company with the least negative ROIC to WACC ratio at -1.56. Despite its negative ROIC of -11.66%, Brightcove's WACC is 7.48%, suggesting it is relatively closer to covering its cost of capital compared to others. This positions Brightcove as a relatively better performer in terms of capital efficiency.

ClearPoint Neuro, Inc. and Rekor Systems, Inc. show more significant challenges with ROICs of -40.55% and -107.12%, respectively. Their ROIC to WACC ratios of -5.20 and -8.14 indicate a substantial gap between the returns generated and the cost of capital. This suggests that these companies face more significant hurdles in achieving capital efficiency.

DarioHealth Corp. and Apyx Medical Corporation also struggle with negative ROICs of -18.93% and -26.00%, respectively. Their ROIC to WACC ratios of -2.82 and -2.27 reflect ongoing challenges in generating returns that exceed their cost of capital. These figures underscore the broader issue of capital inefficiency across the peer group, with Brightcove Inc. standing out as the relatively better performer.

Published on: August 13, 2025